TY - JOUR AU - Bailar, J. C. AU - Gornik, H. L. PY - 1997 DA - 1997// TI - Cancer undefeated. JO - N Engl J Med VL - 336 UR - https://doi.org/10.1056/NEJM199705293362206 DO - 10.1056/NEJM199705293362206 ID - Bailar1997 ER - TY - JOUR AU - Landis, S. H. AU - Murray, T. AU - Bolden, S. AU - Wingo, P. A. PY - 1999 DA - 1999// TI - Cancer statistics, 1999. JO - CA Cancer J Clin VL - 49 UR - https://doi.org/10.3322/canjclin.49.1.8 DO - 10.3322/canjclin.49.1.8 ID - Landis1999 ER - TY - JOUR AU - Early Breast Cancer Trialists' Collaborative Group: PY - 1992 DA - 1992// TI - Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group. JO - Lancet VL - 339 ID - Early Breast Cancer Trialists' Collaborative Group:1992 ER - TY - JOUR AU - Brinkley, D. AU - Haybittle, J. L. PY - 1977 DA - 1977// TI - The curability of breast cancer. JO - World J Surg VL - 1 UR - https://doi.org/10.1007/BF01556839 DO - 10.1007/BF01556839 ID - Brinkley1977 ER - TY - JOUR AU - Brinkley, D. AU - Haybrittle, J. L. PY - 1975 DA - 1975// TI - The curability of breast cancer. JO - Lancet VL - 2 UR - https://doi.org/10.1016/S0140-6736(75)90003-3 DO - 10.1016/S0140-6736(75)90003-3 ID - Brinkley1975 ER - TY - JOUR AU - Duncan, W. AU - Kerr, G. R. PY - 1976 DA - 1976// TI - The curability of breast cancer. JO - Br Med J VL - 2 UR - https://doi.org/10.1136/bmj.2.6039.781 DO - 10.1136/bmj.2.6039.781 ID - Duncan1976 ER - TY - CHAP AU - Easson, E. C. AU - Russell, M. H. PY - 1968 DA - 1968// BT - Curability of Cancer in Various Sites: 4th Statistical Report. Baltimore: Williams & Wilkins, ID - Easson1968 ER - TY - JOUR AU - Pocock, S. J. AU - Gore, S. M. AU - Kerr, G. R. PY - 1982 DA - 1982// TI - Long term survival analysis: the curability of breast cancer. JO - Stat Med VL - 1 UR - https://doi.org/10.1002/sim.4780010202 DO - 10.1002/sim.4780010202 ID - Pocock1982 ER - TY - JOUR AU - Karrison, T. G. AU - Ferguson, D. J. AU - Meier, P. PY - 1999 DA - 1999// TI - Dormancy of mammary carcinoma after mastectomy. JO - J Natl Cancer Inst VL - 91 UR - https://doi.org/10.1093/jnci/91.1.80 DO - 10.1093/jnci/91.1.80 ID - Karrison1999 ER - TY - JOUR AU - Saphner, T. AU - Tormey, D. C. AU - Gray, R. PY - 1996 DA - 1996// TI - Annual hazard rates of recurrence for breast cancer after primary therapy. JO - J Clin Oncol VL - 14 ID - Saphner1996 ER - TY - JOUR AU - Skipper, H. E. PY - 1986 DA - 1986// TI - On mathematical modeling of critical variables in cancer treatment (goals: better understanding of the past and better planning in the future). JO - Bull Math Biol VL - 48 UR - https://doi.org/10.1007/BF02459681 DO - 10.1007/BF02459681 ID - Skipper1986 ER - TY - JOUR AU - Retsky, M. W. AU - Demicheli, R. AU - Swartzendruber, D. E. AU - Bame, P. D. AU - Wardwell, R. H. AU - Bonadonna, G. AU - Speer, J. F. AU - Valagussa, P. PY - 1997 DA - 1997// TI - Computer simulation of a breast cancer metastasis model. JO - Breast Cancer Res Treat VL - 45 UR - https://doi.org/10.1023/A:1005849301420 DO - 10.1023/A:1005849301420 ID - Retsky1997 ER - TY - JOUR AU - Speer, J. F. AU - Petrosky, V. E. AU - Retsky, M. W. AU - Wardwell, R. H. PY - 1984 DA - 1984// TI - A stochastic numerical model of breast cancer growth that simulates clinical data. JO - Cancer Res VL - 44 ID - Speer1984 ER - TY - JOUR AU - Norton, L. AU - Simon, R. PY - 1986 DA - 1986// TI - The Norton-Simon hypothesis revisited. JO - Cancer Treat Rep VL - 70 ID - Norton1986 ER - TY - JOUR AU - Norton, L. AU - Simon, R. PY - 1977 DA - 1977// TI - Tumor size, sensitivity to therapy, and design of treatment schedules. JO - Cancer Treat Rep VL - 61 ID - Norton1977 ER - TY - JOUR AU - Norton, L. AU - Simon, R. PY - 1977 DA - 1977// TI - Growth curve of an experimental solid tumor following radiotherapy. JO - J Natl Cancer Inst VL - 58 ID - Norton1977 ER - TY - JOUR AU - Spratt, J. A. AU - von Fournier, D. AU - Spratt, J. S. AU - Weber, E. E. PY - 1993 DA - 1993// TI - Decelerating growth and human breast cancer. JO - Cancer VL - 71 UR - https://doi.org/3.0.CO;2-V DO - 3.0.CO;2-V ID - Spratt1993 ER - TY - JOUR AU - Spratt, J. A. AU - von Fournier, D. AU - Spratt, J. S. AU - Weber, E. E. PY - 1993 DA - 1993// TI - Mammographic assessment of human breast cancer growth and duration. JO - Cancer VL - 71 UR - https://doi.org/3.0.CO;2-# DO - 3.0.CO;2-# ID - Spratt1993 ER - TY - JOUR AU - Koscielny, S. AU - Tubiana, M. AU - Valleron, A. J. PY - 1985 DA - 1985// TI - A simulation model of the natural history of human breast cancer. JO - Br J Cancer VL - 52 UR - https://doi.org/10.1038/bjc.1985.222 DO - 10.1038/bjc.1985.222 ID - Koscielny1985 ER - TY - JOUR AU - Norton, L. AU - Simon, R. AU - Brereton, H. D. AU - Bogden, A. E. PY - 1976 DA - 1976// TI - Predicting the course of Gompertzian growth. JO - Nature VL - 264 UR - https://doi.org/10.1038/264542a0 DO - 10.1038/264542a0 ID - Norton1976 ER - TY - JOUR AU - Bloom, H. J. G. AU - Richardson, W. W. AU - Harries, E. J. PY - 1962 DA - 1962// TI - Natural history of untreated breast cancer (1805-1933) comparison of untreated and treated cases according to histogical grade of malignancy. JO - Br Med J VL - 2 UR - https://doi.org/10.1136/bmj.2.5299.213 DO - 10.1136/bmj.2.5299.213 ID - Bloom1962 ER - TY - JOUR AU - Sullivan, P. W. AU - Salmon, S. E. PY - 1972 DA - 1972// TI - Kinetics of tumor growth and regression in IgG multiple myeloma. JO - J Clin Invest VL - 51 UR - https://doi.org/10.1172/JCI106971 DO - 10.1172/JCI106971 ID - Sullivan1972 ER - TY - JOUR AU - Heuser, L. AU - Spratt, J. AU - Polk, H. PY - 1979 DA - 1979// TI - Growth rates of primary breast cancer. JO - Cancer (Phil) VL - 43 UR - https://doi.org/3.0.CO;2-M DO - 3.0.CO;2-M ID - Heuser1979 ER - TY - JOUR AU - Retsky, M. W. AU - Swartzendruber, D. E. AU - Wardwell, R. H. AU - Bame, P. D. PY - 1990 DA - 1990// TI - Is Gompertzian or exponential kinetics a valid description of individual human cancer growth? JO - Med Hypotheses VL - 33 UR - https://doi.org/10.1016/0306-9877(90)90186-I DO - 10.1016/0306-9877(90)90186-I ID - Retsky1990 ER - TY - JOUR AU - Holmgren, L. AU - O'Reilly, M. S. AU - Folkman, J. PY - 1995 DA - 1995// TI - Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. JO - Nature Med VL - 1 UR - https://doi.org/10.1038/nm0295-149 DO - 10.1038/nm0295-149 ID - Holmgren1995 ER - TY - JOUR AU - Folkman, J. PY - 1996 DA - 1996// TI - New perspectives in clinical oncology from angiogenesis research. JO - Eur J Cancer VL - 32A UR - https://doi.org/10.1016/S0959-8049(96)00423-6 DO - 10.1016/S0959-8049(96)00423-6 ID - Folkman1996 ER - TY - JOUR AU - Folkman, J. PY - 1996 DA - 1996// TI - Fighting cancer by attacking its blood supply. JO - Sci Am VL - 275 UR - https://doi.org/10.1038/scientificamerican0996-150 DO - 10.1038/scientificamerican0996-150 ID - Folkman1996 ER - TY - JOUR AU - Folkman, J. PY - 1995 DA - 1995// TI - Angiogenesis in cancer, vascular, rheumatoid and other disease. JO - Nature Med VL - 1 UR - https://doi.org/10.1038/nm0195-27 DO - 10.1038/nm0195-27 ID - Folkman1995 ER - TY - JOUR AU - Norton, L. PY - 1988 DA - 1988// TI - A Gompertzian model of human breast cancer growth. JO - Cancer Res VL - 48 ID - Norton1988 ER - TY - JOUR AU - Retsky, M. AU - Swartzendruber, D. AU - Wardell, R. AU - Bame, P. AU - Petrosky, V. PY - 1989 DA - 1989// TI - Re: Larry Norton, a Gompertzian model of human breast cancer growth [letter; comment]. JO - Cancer Res VL - 49 ID - Retsky1989 ER - TY - JOUR AU - Fletcher, S. W. AU - Black, W. AU - Harris, R. AU - Rimer, B. K. AU - Shapiro, S. PY - 1993 DA - 1993// TI - Report of the International Workshop on Screening for Breast Cancer [see comments]. JO - J Natl Cancer Inst VL - 85 UR - https://doi.org/10.1093/jnci/85.20.1644 DO - 10.1093/jnci/85.20.1644 ID - Fletcher1993 ER - TY - JOUR AU - Skipper, H. E. AU - Schabel, F. M. AU - Wilcox, W. S. PY - 1964 DA - 1964// TI - Experimental evaluation of potential anticancer agents: XIII. On the criteria and kinetics associated with 'curability' of experimental leukemia. JO - Cancer Chemother Rep VL - 35 ID - Skipper1964 ER - TY - JOUR AU - Luria, S. E. AU - Delbruck, M. PY - 1943 DA - 1943// TI - Mutations of bacteria from virus sensitivity to virus resistance. JO - Genetics VL - 28 ID - Luria1943 ER - TY - JOUR AU - Law, L. W. PY - 1952 DA - 1952// TI - Origin of the resistance of leukaemic cells to folic acid antagonists. JO - Nature VL - 169 UR - https://doi.org/10.1038/169628a0 DO - 10.1038/169628a0 ID - Law1952 ER - TY - JOUR AU - Goldie, J. H. AU - Coldman, A. J. PY - 1979 DA - 1979// TI - A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. JO - Cancer Treat Rep VL - 63 ID - Goldie1979 ER - TY - JOUR AU - Goldie, J. H. AU - Coldman, A. J. AU - Gudauskas, G. A. PY - 1982 DA - 1982// TI - Rationale for the use of alternating non-cross-resistant chemotherapy. JO - Cancer Treat Rep VL - 66 ID - Goldie1982 ER - TY - JOUR AU - Panetta, J. C. PY - 1998 DA - 1998// TI - A mathematical model of drug resisitance: heterogeneous tumors. JO - Math Biosci VL - 147 UR - https://doi.org/10.1016/S0025-5564(97)00080-1 DO - 10.1016/S0025-5564(97)00080-1 ID - Panetta1998 ER - TY - JOUR AU - Retsky, M. W. AU - Swartzendruber, D. E. AU - Bame, P. D. AU - Wardell, R. H. PY - 1994 DA - 1994// TI - Computer model challenges breast cancer treatment strategy. JO - Cancer Invest VL - 12 UR - https://doi.org/10.3109/07357909409023040 DO - 10.3109/07357909409023040 ID - Retsky1994 ER - TY - JOUR AU - Demicheli, R. AU - Retsky, M. W. AU - Swartzendruber, D. E. AU - Bonadonna, G. PY - 1997 DA - 1997// TI - Proposal for a new model of breast cancer metastatic development. JO - Ann Oncol VL - 8 UR - https://doi.org/10.1023/A:1008263116022 DO - 10.1023/A:1008263116022 ID - Demicheli1997 ER - TY - JOUR AU - Swartzendruber, D. E. AU - Retsky, M. W. AU - Wardwell, R. H. AU - Bame, P. D. PY - 1994 DA - 1994// TI - An alternative approach for treatment of breast cancer. JO - Breast Cancer Res Treat VL - 32 UR - https://doi.org/10.1007/BF00666009 DO - 10.1007/BF00666009 ID - Swartzendruber1994 ER - TY - JOUR AU - Demicheli, R. AU - Miceli, R. AU - Brambilla, C. AU - Ferrari, L. AU - Moliterni, A. AU - Zambetti, M. AU - Valagussa, P. AU - Bonadonna, G. PY - 1999 DA - 1999// TI - Comparative analysis of breast cancer recurrence risk for patients receiving or not receiving adjuvant cyclophosphamide, methotrexate, fluorouracil (CMF). Data supporting the occurrence of 'cures'. JO - Breast Cancer Res Treat VL - 53 UR - https://doi.org/10.1023/A:1006134702484 DO - 10.1023/A:1006134702484 ID - Demicheli1999 ER - TY - JOUR AU - Buzzoni, R. AU - Bonadonna, G. AU - Valagussa, P. AU - Zambetti, M. PY - 1991 DA - 1991// TI - Adjuvant chemotherapy with doxorubicin plus cyclophosphamide, methotrexate, and fluorouracil in the treatment of resectable breast cancer with more than three positive axillary nodes. JO - J Clin Oncol VL - 9 ID - Buzzoni1991 ER - TY - JOUR AU - International Breast Cancer Study Group: PY - 1996 DA - 1996// TI - Duration and reintroduction of adjuvant chemotherapy for node-positive premenopausal breast cancer patients. International Breast Cancer Study Group. JO - J Clin Oncol VL - 14 ID - International Breast Cancer Study Group:1996 ER -